Heritas Capital

Heritas Capital is a private equity and venture capital investment firm based in Singapore, founded in 1997 as part of the IMC Group. The firm specializes in investments within the healthcare, education, and technology sectors, primarily targeting opportunities across the Asia-Pacific region. By leveraging its expertise and regional insights, Heritas Capital aims to support the growth and development of innovative companies within these key industries.

Janet Chia

Managing Director and Head of Private Equity

Chik Wai Chiew

CEO and Executive Director

Charis Goh

Director

Anselm Cian Tan

Managing Director and Head Of Venture Capital

31 past transactions

Kreedo is an Edtech company that offers customers an end-to-end solution, from naming their preschool, marketing support, layout, admissions process, and so on, to running a premium preschool, which includes curriculum, educational materials, teacher and owner training, and assessment solutions.

The Gentle Group

Venture Round in 2024
The Gentle Group develops familiar, pleasant, nutritious soft meals that stimulate the appetite by their appearance, taste, and scent, restoring the joy of food to persons who have difficulty swallowing

ConveGenius

Series A in 2024
ConveGenius is a social enterprise focused on creating sustainable educational impact through its technology platforms. It offers personalized and adaptive learning solutions via its PAL platform, which tailors content to meet the unique needs of individual students. The platform incorporates gamification and adaptive analytics, making education more engaging and accessible. Additionally, it provides real-time impact dashboards that deliver valuable data and insights to stakeholders, enhancing decision-making and supporting continuous improvement in educational implementation. ConveGenius aims to leverage conversational AI and big data analytics to drive meaningful change in emerging markets, ultimately facilitating affordable access to formal education for learners.

Bettr Group

Seed Round in 2023
Bettr Group is a coffee company that wholesales and retails coffee bars and equipment.

Cakap

Series C in 2023
Cakap is an Indonesian EdTech company that offers an online learning platform focused on language acquisition and skill development. The platform connects students with professional teachers and industry experts, facilitating interactive and engaging learning experiences. By utilizing live interactions with native instructors and multimedia content, Cakap enhances conversational skills and promotes effective language learning. The platform is accessible through various devices, including mobile apps and desktop, catering to a wide range of users. Cakap is dedicated to providing high-quality education through an internationally recognized curriculum, ensuring that learners can conveniently study from home or their workplace.

Alchemy FoodTech

Convertible Note in 2022
Alchemy FoodTech is a food science and technology company focused on developing innovative active food ingredients aimed at combating diabetes. The company emphasizes preventive healthcare, striving to ensure that individuals do not develop diabetes in the first place. By integrating advanced food, bio, and medical technologies into everyday foods, Alchemy FoodTech enhances disease management for diabetics and promotes diabetes prevention for the general public. They offer a plant-based fiber blend designed to slow glucose release from refined carbohydrates, such as white rice, while also providing a higher fiber content than brown rice. This powdered blend can be easily incorporated into meals without altering the taste, texture, or appearance of the food, helping users achieve a balanced diet.

Tessa Therapeutics

Series A in 2022
Tessa Therapeutics is a biotechnology company focused on developing innovative T cell therapies for the treatment of cancer, particularly solid tumors and lymphoma. The company specializes in creating virus-specific T cells and CAR T cells, leveraging the body's natural immune response to target and eliminate cancer cells. By advancing both autologous and allogeneic cell therapy approaches, Tessa Therapeutics aims to transform cancer treatment, providing healthcare providers with new tools to improve patient outcomes and enhance the quality of life for those affected by cancer.

HealthBeats

Seed Round in 2022
HealthBeats is a subscription-based platform focused on remote patient monitoring. It provides a comprehensive solution for patients and healthcare providers through a combination of regulatory-approved medical devices, a user-friendly software platform, and dedicated support services. The platform enables patients to self-administer medical devices from various brands at home and transmit their health data in real-time to their providers. This approach facilitates proactive care management, aiming to enhance patient outcomes while reducing healthcare costs. By empowering patients to monitor their own health effectively, HealthBeats supports a more engaged and informed patient population.

Cakap

Series B in 2021
Cakap is an Indonesian EdTech company that offers an online learning platform focused on language acquisition and skill development. The platform connects students with professional teachers and industry experts, facilitating interactive and engaging learning experiences. By utilizing live interactions with native instructors and multimedia content, Cakap enhances conversational skills and promotes effective language learning. The platform is accessible through various devices, including mobile apps and desktop, catering to a wide range of users. Cakap is dedicated to providing high-quality education through an internationally recognized curriculum, ensuring that learners can conveniently study from home or their workplace.

Pintek

Series A in 2021
Pintek is a financial technology company focused on increasing access to education in Indonesia by providing affordable and flexible credit solutions. It offers a range of financing services, including bailouts, working capital loans, and installment plans, tailored specifically for educational purposes. Pintek's innovative approach includes a non-collateral repayment program, which simplifies the loan process for clients and educational institutions. By prioritizing accessibility and ease of use, Pintek aims to support students and educational providers in overcoming financial barriers to education.

ConveGenius

Seed Round in 2021
ConveGenius is a social enterprise focused on creating sustainable educational impact through its technology platforms. It offers personalized and adaptive learning solutions via its PAL platform, which tailors content to meet the unique needs of individual students. The platform incorporates gamification and adaptive analytics, making education more engaging and accessible. Additionally, it provides real-time impact dashboards that deliver valuable data and insights to stakeholders, enhancing decision-making and supporting continuous improvement in educational implementation. ConveGenius aims to leverage conversational AI and big data analytics to drive meaningful change in emerging markets, ultimately facilitating affordable access to formal education for learners.

mfine

Series C in 2021
Mfine is an health-tech startup that offers an AI-powered online doctor consultation app. Their doctors have access to a proprietary Assistive Intelligence platform that can analyze the symptoms and deliver accurate prognosis for the specialist to assess patients. This means, the doctor knows about patients' condition even before they’ve seen them, making the diagnosis quicker and sharper. Mfine aims to make access to trusted healthcare simple, fast and proactive. With a combination of new-age technology and partnerships with best in class hospitals/clinics, they designed mfine keeping consumer experience at its core. Mfine brings in instant and continuous connectivity with top doctors of the best hospitals. It uses cutting edge technology to keep track of your health parameters and keep all your health data in your control and easily accessible. Digital wearable devices, mobile app, and at-home services bring in the much-needed convenience and speed in getting you the right care when you need it. Mfine was founded in 2017 and is based in Bengaluru.

Hummingbird Bioscience

Series C in 2021
Hummingbird Bioscience focuses on the development of innovative therapeutic antibody-based drugs aimed at addressing significant unmet needs in oncology and immuno-oncology. Utilizing a proprietary rational antibody discovery platform, the company leverages systems biology and computational methods to gain insights into disease mechanisms, guiding the discovery and engineering of new biotherapeutics. Hummingbird's pipeline includes promising drug candidates such as HMBD-001, an anti-HER3 antibody, and HMBD-002, an anti-VISTA antibody, both targeting cancer treatment. The company has formed strategic collaborations with organizations like Cancer Research UK and Amgen and has received a product development grant from the Cancer Prevention and Research Institute of Texas. This collaborative approach enhances Hummingbird's capacity to deliver effective therapies for patients with challenging medical conditions.

mfine

Venture Round in 2021
Mfine is an health-tech startup that offers an AI-powered online doctor consultation app. Their doctors have access to a proprietary Assistive Intelligence platform that can analyze the symptoms and deliver accurate prognosis for the specialist to assess patients. This means, the doctor knows about patients' condition even before they’ve seen them, making the diagnosis quicker and sharper. Mfine aims to make access to trusted healthcare simple, fast and proactive. With a combination of new-age technology and partnerships with best in class hospitals/clinics, they designed mfine keeping consumer experience at its core. Mfine brings in instant and continuous connectivity with top doctors of the best hospitals. It uses cutting edge technology to keep track of your health parameters and keep all your health data in your control and easily accessible. Digital wearable devices, mobile app, and at-home services bring in the much-needed convenience and speed in getting you the right care when you need it. Mfine was founded in 2017 and is based in Bengaluru.

Cakap

Series A in 2020
Cakap is an Indonesian EdTech company that offers an online learning platform focused on language acquisition and skill development. The platform connects students with professional teachers and industry experts, facilitating interactive and engaging learning experiences. By utilizing live interactions with native instructors and multimedia content, Cakap enhances conversational skills and promotes effective language learning. The platform is accessible through various devices, including mobile apps and desktop, catering to a wide range of users. Cakap is dedicated to providing high-quality education through an internationally recognized curriculum, ensuring that learners can conveniently study from home or their workplace.

Alchemy FoodTech

Venture Round in 2020
Alchemy FoodTech is a food science and technology company focused on developing innovative active food ingredients aimed at combating diabetes. The company emphasizes preventive healthcare, striving to ensure that individuals do not develop diabetes in the first place. By integrating advanced food, bio, and medical technologies into everyday foods, Alchemy FoodTech enhances disease management for diabetics and promotes diabetes prevention for the general public. They offer a plant-based fiber blend designed to slow glucose release from refined carbohydrates, such as white rice, while also providing a higher fiber content than brown rice. This powdered blend can be easily incorporated into meals without altering the taste, texture, or appearance of the food, helping users achieve a balanced diet.

Alodokter

Series C in 2020
Alodokter is a digital health platform based in Indonesia that offers a comprehensive solution for patients seeking healthcare services. It provides telemedicine services, allowing users to consult with qualified doctors remotely. The platform also features credible health information, supportive communities, and extensive reference materials on health topics, empowering users to make informed decisions regarding their health. Additionally, Alodokter facilitates the booking of doctor appointments and offers guidance on illnesses, treatments, and healthy living. By integrating these services, Alodokter aims to enhance the healthcare experience for Indonesian patients and improve access to reliable health resources.

The Gentle Group

Seed Round in 2020
The Gentle Group develops familiar, pleasant, nutritious soft meals that stimulate the appetite by their appearance, taste, and scent, restoring the joy of food to persons who have difficulty swallowing

Hummingbird Bioscience

Series B in 2019
Hummingbird Bioscience focuses on the development of innovative therapeutic antibody-based drugs aimed at addressing significant unmet needs in oncology and immuno-oncology. Utilizing a proprietary rational antibody discovery platform, the company leverages systems biology and computational methods to gain insights into disease mechanisms, guiding the discovery and engineering of new biotherapeutics. Hummingbird's pipeline includes promising drug candidates such as HMBD-001, an anti-HER3 antibody, and HMBD-002, an anti-VISTA antibody, both targeting cancer treatment. The company has formed strategic collaborations with organizations like Cancer Research UK and Amgen and has received a product development grant from the Cancer Prevention and Research Institute of Texas. This collaborative approach enhances Hummingbird's capacity to deliver effective therapies for patients with challenging medical conditions.

Alodokter

Series C in 2019
Alodokter is a digital health platform based in Indonesia that offers a comprehensive solution for patients seeking healthcare services. It provides telemedicine services, allowing users to consult with qualified doctors remotely. The platform also features credible health information, supportive communities, and extensive reference materials on health topics, empowering users to make informed decisions regarding their health. Additionally, Alodokter facilitates the booking of doctor appointments and offers guidance on illnesses, treatments, and healthy living. By integrating these services, Alodokter aims to enhance the healthcare experience for Indonesian patients and improve access to reliable health resources.

Pathstream

Series A in 2019
Pathstream is a web-based platform focused on teaching in-demand tech skills for the workforce. By partnering with leading technology companies and higher education institutions, Pathstream transforms digital skill learning into a practical experience. The platform offers students immediate access to pre-configured, project-based instruction, realistic workplace simulations, and on-demand coaching. This approach enables learners to acquire the essential digital skills needed to thrive in today’s job market.

Hummingbird Bioscience

Series A in 2019
Hummingbird Bioscience focuses on the development of innovative therapeutic antibody-based drugs aimed at addressing significant unmet needs in oncology and immuno-oncology. Utilizing a proprietary rational antibody discovery platform, the company leverages systems biology and computational methods to gain insights into disease mechanisms, guiding the discovery and engineering of new biotherapeutics. Hummingbird's pipeline includes promising drug candidates such as HMBD-001, an anti-HER3 antibody, and HMBD-002, an anti-VISTA antibody, both targeting cancer treatment. The company has formed strategic collaborations with organizations like Cancer Research UK and Amgen and has received a product development grant from the Cancer Prevention and Research Institute of Texas. This collaborative approach enhances Hummingbird's capacity to deliver effective therapies for patients with challenging medical conditions.

ReUp Education

Series A in 2019
ReUp Education, Inc. is a San Francisco-based company that offers specialized marketing and consulting services to educational institutions aimed at re-enrolling students who have left college. Founded in 2015, ReUp utilizes data, technology, and personalized coaching to support these students in navigating their paths back to graduation. The company partners with universities and community colleges to engage and empower individuals who have dropped out, addressing various barriers to completion, such as financial challenges, work obligations, and motivational issues. By providing services that include goal-setting, study habits, financial management, and career preparation, ReUp helps students complete their remaining credits and achieve their educational goals. The organization addresses the significant issue of student dropouts in the United States, where millions have left college without degrees, often burdened by debt.

Alchemy FoodTech

Seed Round in 2019
Alchemy FoodTech is a food science and technology company focused on developing innovative active food ingredients aimed at combating diabetes. The company emphasizes preventive healthcare, striving to ensure that individuals do not develop diabetes in the first place. By integrating advanced food, bio, and medical technologies into everyday foods, Alchemy FoodTech enhances disease management for diabetics and promotes diabetes prevention for the general public. They offer a plant-based fiber blend designed to slow glucose release from refined carbohydrates, such as white rice, while also providing a higher fiber content than brown rice. This powdered blend can be easily incorporated into meals without altering the taste, texture, or appearance of the food, helping users achieve a balanced diet.

Alchemy FoodTech

Seed Round in 2018
Alchemy FoodTech is a food science and technology company focused on developing innovative active food ingredients aimed at combating diabetes. The company emphasizes preventive healthcare, striving to ensure that individuals do not develop diabetes in the first place. By integrating advanced food, bio, and medical technologies into everyday foods, Alchemy FoodTech enhances disease management for diabetics and promotes diabetes prevention for the general public. They offer a plant-based fiber blend designed to slow glucose release from refined carbohydrates, such as white rice, while also providing a higher fiber content than brown rice. This powdered blend can be easily incorporated into meals without altering the taste, texture, or appearance of the food, helping users achieve a balanced diet.

mfine

Venture Round in 2017
Mfine is an health-tech startup that offers an AI-powered online doctor consultation app. Their doctors have access to a proprietary Assistive Intelligence platform that can analyze the symptoms and deliver accurate prognosis for the specialist to assess patients. This means, the doctor knows about patients' condition even before they’ve seen them, making the diagnosis quicker and sharper. Mfine aims to make access to trusted healthcare simple, fast and proactive. With a combination of new-age technology and partnerships with best in class hospitals/clinics, they designed mfine keeping consumer experience at its core. Mfine brings in instant and continuous connectivity with top doctors of the best hospitals. It uses cutting edge technology to keep track of your health parameters and keep all your health data in your control and easily accessible. Digital wearable devices, mobile app, and at-home services bring in the much-needed convenience and speed in getting you the right care when you need it. Mfine was founded in 2017 and is based in Bengaluru.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.